MedTrace Logo

Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy

NCT03845764 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164

Last updated 2019-08-15

No results posted yet for this study

Summary

The study is aimed at verifying if a pulmonologist can reliably assess the tumor burden for the extractive molecular analysis in ROSE samples obtained with endoscopic sampling procedures from intrathoracic lymphadenopathy and pulmonary nodules.

Conditions

Interventions

DIAGNOSTIC_TEST

Rapid on-site evaluation

Specimens obtained with endoscopic sampling procedures are stained with a rapid method (i.e., Diff Qui) and submitted to on-site cytologic review

Sponsors & Collaborators

  • Maggiore Bellaria Hospital, Bologna

    lead OTHER

Principal Investigators

  • Rocco Trisolini, MD · Policlinico S. Orsola, Bologna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2019-06-30
Completion
2019-07-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03845764 on ClinicalTrials.gov